Bausch Health Companies (BHC) Long-Term Investments (2009 - 2012)
Bausch Health Companies (BHC) reported Long-Term Investments of $7.2 million for Q4 2012, down 21.84% sequentially from $9.2 million in Q2 2011.
Bausch Health Companies (BHC) Long-Term Investments (2009 - 2012) Analysis & Trends
Bausch Health Companies (BHC) has 4 years of Long-Term Investments data on file, last reported at $7.2 million in Q4 2012.
- For the quarter ending Q4 2012, Long-Term Investments changed N/A year-over-year to $7.2 million; the trailing twelve-month figure through Dec 2012 stood at $7.2 million (changed N/A YoY), and the FY2012 full-year result was $7.2 million, changed N/A from the prior year.
- Long-Term Investments fell to $7.2 million in Q4 2012, from $9.2 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $80.0 million in Q1 2011 to a low of $2.1 million in Q4 2010.
- A 4-year average of $17.6 million and a median of $9.2 million in 2011 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments plunged 81.91% in 2010 and declined 5.07% in 2011, its largest moves.
- Tracing BHC's Long-Term Investments over 4 years: stood at $11.5 million in 2009, then sank by 81.91% to $2.1 million in 2010, then surged by 340.23% to $9.2 million in 2011, then fell by 21.84% to $7.2 million in 2012.
- Business Quant data shows BHC's Long-Term Investments at $7.2 million in Q4 2012, $9.2 million in Q2 2011, and $80.0 million in Q1 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 7.17 Mn |
| Jun 30, 2011 | 9.17 Mn |
| Mar 31, 2011 | 79.95 Mn |
| Dec 31, 2010 | 2.08 Mn |
| Sep 30, 2010 | 3.65 Mn |
| Jun 30, 2010 | 9.66 Mn |
| Dec 31, 2009 | 11.52 Mn |